If pancreatic cancer was suspected, the initial diagnostic test would be a CT or computerised scan of the abdomen. It is able to detect any pancreatic mass greater than 2cm, 95% of the time. Smaller tumours are more difficult to detect.
When a fibreoptic scope is used to look into the stomach and small intestine where the ducts of the pancreas drain, the procedure is called an endoscopic retrograde cholangiopancreaticography (ERCP). X-ray dye is injected into the ducts of the pancreas and x-rays taken of the pancreas. Irregularities of the pancreatic ducts can then be seen. Small pieces of tissue can also be biopsied during this procedure. If the ducts are blocked, a small plastic tube, called a stent, can be placed during this same procedure to bypass the block. Potential complications of this procedure include infection of the pancreas and perforation of the small intestine. A stent that is placed will need to be changed every 3 to 4 months because the stent can be blocked by normal secretions from the pancreas.
Clinical examinations, x-rays and pathology reports all help the medical team decide what the progress of an individual case of pancreatic cancer may be. Then, the appropriate course of treatment will be put into action. The treatment strategy will vary from person to person. With prompt and appropriate treatment, the outlook for a person with pancreatic cancer is fair. Even with surgery, about half of patients survive between 2 to 3 years. The chance of surviving to 5 years after curative surgery is about 20%.
Patients with advanced inoperable pancreatic cancer do not normally survive beyond a year.